e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Quality control in lung function and exercise-related issues
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Flow limitation at rest may identify a phenotype of chronic obstructive pulmonary disease (COPD)
L. Malagrinò, F. Costa, B. Vagaggini, C. De Simone, C. Spanu, A. Celi, P. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2011 - Quality control in lung function and exercise-related issues
Session:
Quality control in lung function and exercise-related issues
Session type:
Poster Discussion
Number:
3037
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Malagrinò, F. Costa, B. Vagaggini, C. De Simone, C. Spanu, A. Celi, P. Paggiaro (Pisa, Italy). Flow limitation at rest may identify a phenotype of chronic obstructive pulmonary disease (COPD). Eur Respir J 2011; 38: Suppl. 55, 3037
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005
The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007
Hoover‘s sign predicts expiratory flow limitation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 807s
Year: 2006
Is Hoover‘s sign helpful to detect expiratory flow limitation in chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Quantification of airflow limitation in chronic obstructive pulmonary disease
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018
Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012
Exercise capacity predicts survival in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 488s
Year: 2001
Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Candidate gene associations in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008
Frequency distribution of the novel GOLD-stages in newly diagnosed chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 348s
Year: 2001
Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Regional ventilatory defects in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
The evaluation of a helpline for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2004 - Smoking and cessation in respiratory disease
Year: 2004
Functional illiteracy amongst those with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 57s
Year: 2005
Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
Effect of hospitalization on exercise capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012
Characteristics of blood ammonia response to exercise in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 608s
Year: 2006
Who are they? Characteristics of smokers with previously undetected COPD
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept